Lokelma (sodium zirconium cyclosilicate) is a prescription drug that’s used to treat hyperkalemia (high potassium levels) in adults. The drug comes as a powder you’ll mix with water to drink. Your ...
WILMINGTON, Del.--(BUSINESS WIRE)--Today, the US Food and Drug Administration (FDA) approved a label update in the US for AstraZeneca’s LOKELMA ® (sodium zirconium cyclosilicate) to include a dosing ...
Lokelma is a branded medication that contains sodium zirconium cyclosilicate. It isn’t currently available in generic form. It comes as a powder that you mix into water and then drink. Lokelma powder ...
Please provide your email address to receive an email when new articles are posted on . The FDA has updated the dosing regimen for Lokelma to allow treatment of hyperkalemia in patients with end-stage ...
The prescribing information for Lokelma® (sodium zirconium cyclosilicate; AstraZeneca) has been updated to include a dosing regimen to treat hyperkalemia in patients with end-stage renal disease (ESRD ...
(RTTNews) - AstraZeneca (AZN.L) said the US FDA approved a label update in the US for LOKELMA to include a dosing regimen specifically to treat hyperkalemia in patients with end-stage renal disease on ...
In its first label update since sodium zirconium cyclosilicate was approved in 2018, FDA has a dosage regimen specifically to treat hyperkalemia in stable hemodialysis patients. The FDA has approved a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results